MedCloud Minute
The MedCloud Minute blog is researched, fact-checked, edited and updated by the editors of MedCloudInsider.com, with writing assistance from AI. To submit your company's press release for consideration, contact [email protected].
Cognizant, an AI builder and technology services provider, has expanded its TriZetto Unify platform to support AI agents, enabling healthcare organizations to apply automation and intelligent workflows across operational and patient-facing processes. The new headless API model treats AI agents as first-tier consumers of TriZetto Unify, Cognizant's platform strategy that spans payer and provider workflows. Electronic Prior Authorization is the first solution to go live, following the rollout of TriZetto Assistant and TriZetto Autonomous Workflow Agents to existing customers.
More
Posted by MedCloudInsider Editors on 06/02/20260 comments
The University of Pennsylvania Health System has agreed to a multi-year partnership with K Health to deploy artificial intelligence clinical agents across its electronic health records systems, the companies announced Tuesday, adding the prominent academic medical center to a client roster that already includes several large U.S. health systems.
The collaboration will begin with Penn Medicine On-Demand, the health system's virtual urgent care program, before expanding into in-person primary care and selected specialties, including cardiology and dermatology, across Penn's network of clinics.
More
Posted by MedCloudInsider Editors on 05/31/20260 comments
Healthcare providers are increasingly turning to AI-powered reception systems as staffing shortages, rising call volumes, and patient access challenges continue to strain front-office operations.
A new report from Claire Research, which develops AI voice agents for healthcare organizations, examines adoption trends for AI receptionists across medical practices in 2026. The report argues that demand for automated patient communication tools is being driven by persistent workforce shortages and growing administrative burdens in ambulatory care settings.
More
Posted by MedCloudInsider Editors on 05/31/20260 comments
Fujitsu, Sumitomo Mitsui Financial Group (SMBC Group), and SoftBank Corp. have entered a basic agreement to develop a Japan-built health data platform and AI-powered personal health application, the companies announced on May 19.
With more than 30% of Japan's citizens over 65, the country's aging population is driving a surge in healthcare demand and medical costs. Fragmented health data systems and data sovereignty concerns have underscored the need for a secure, interoperable, and domestically developed platform. SoftBank executives also pointed to Japan's "2040 Problem," in which a shrinking working-age population and rising healthcare costs are expected to put growing pressure on younger generations' disposable incomes, potentially worsening the country's declining birthrate.
More
Posted by MedCloudInsider Editors on 05/29/20260 comments
AstraZeneca and Roche Diagnostics Asia Pacific have signed a three-year memorandum of understanding to accelerate the adoption of AI-powered digital pathology and biomarker testing for breast and lung cancer across nine Asian markets, the companies announced.
The collaboration covers Singapore, Taiwan, Korea, Thailand, Malaysia, India, Indonesia, Vietnam, and the Philippines, and will support education and training initiatives to improve HER2 assessment in breast cancer and TROP2 assessment in non-small cell lung cancer.
More
Posted by MedCloudInsider Editors on 05/29/20260 comments
Insilico Medicine and Human Longevity announced a collaboration to co-develop what the companies describe as an AI foundation model focused on longevity science and aging research. The initiative will combine biological, clinical and longevity-related datasets to create AI models capable of supporting research into aging mechanisms, disease prevention, and healthspan extension. The goal is to accelerate scientific discovery and improve understanding of age-related conditions through large-scale computational analysis.
More
Posted by MedCloudInsider Editors on 05/26/20260 comments
Virtual Science AI, a medical intelligence platform company exclusively for life sciences, has launched Medical Competitor AI, an artificial intelligence–powered competitor activity tracking platform aimed at supporting pharmaceutical companies during product launches. The platform uses AI to monitor and analyze competitor activity, market developments, and commercial trends related to pharmaceutical assets. The goal is to help life sciences organizations respond more quickly to changing market conditions and improve launch planning strategies.
More
Posted by MedCloudInsider Editors on 05/18/20260 comments
Anthill, a transformational Content Excellence company focused on the life sciences industry, has launched Anthill Cloud, an AI-powered content platform designed for the U.S. life sciences market, targeting content creation, compliance, and operational workflows. As a connected cloud platform purpose-built for pharmaceutical, biotech, and MedTech commercial and medical teams, the platform integrates AI-powered content creation, modular authoring, and personalized HCP engagement into a single, compliance-ready ecosystem.
More
Posted by MedCloudInsider Editors on 05/18/20260 comments
Cellular Intelligence, an AI-native technology and biotechnology company, announced an agreement with Novo Nordisk to advance a clinical-stage cell therapy for Parkinson’s disease. The acquisition of Novo's cell-therapy program for Parkinson's will focus on developing therapies that use artificial intelligence to support research, optimization and clinical development processes. The effort targets Parkinson’s disease, a neurodegenerative disorder that affects millions worldwide and remains difficult to treat with existing therapies.
More
Posted by MedCloudInsider Editors on 05/11/20260 comments
The Coalition for Health AI (CHAI), a coalition driving responsible AI adoption in health sciences, has released a set of best practice guides aimed at supporting responsible use of artificial intelligence in Medicaid eligibility systems. The guidance is intended to help healthcare agencies and technology providers address issues such as fairness, transparency, accountability and oversight when deploying AI tools in public healthcare programs. The recommendations focus on ensuring that AI-driven eligibility decisions remain explainable and aligned with regulatory and ethical standards.
More
Posted by MedCloudInsider Editors on 05/11/20260 comments
Converge Bio, a developer of AI platforms for biotech and pharmaceutical companies, announced it is using its ConvergeAB platform, an antibody design and optimization solution, to improve the development of cancer treatments through artificial intelligence–driven design. The platform allows researchers to generate and refine therapeutic approaches using prompt-based interactions, enabling faster iteration in drug development.
More
Posted by MedCloudInsider Editors on 05/05/20260 comments
Conscientia Health, a healthcare organization delivering integrated health services through AI-powered telehealth and hybrid care models, has launched a virtual primary care platform designed to combine mental and physical healthcare services using artificial intelligence. The telehealth offering provides patients with access to integrated care through a single virtual environment, supporting services such as primary care consultations, mental health support, and ongoing care management. The platform uses AI to assist with patient engagement, care coordination, and data analysis. Powered by AI and advanced technology, the platform offers all-in-one integrative care features and is able to analyze integrated datasets, streamline workflows and enable real-time collaboration.
More
Posted by MedCloudInsider Editors on 04/27/20260 comments